help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on June 9, 2005, doi:10.1164/rccm.200503-439OC

Am. J. Respir. Crit. Care Med., Volume 172, Number 6, September 2005, 738-744

A more recent version of this article appeared on September 15, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200503-439OCv1
172/6/738    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carpagnano, G. E.
Right arrow Articles by Paradiso, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carpagnano, G. E.
Right arrow Articles by Paradiso, A.

Submitted on March 21, 2005
Accepted on June 6, 2005

3P Microsatellite Alterations in Exhaled Breath Condensate from Non-small Cell Lung Cancer Patients

Giovanna Elisiana Carpagnano1*, Maria Pia Foschino-Barbaro1, Giuseppina Mule2, Onofrio Resta3, Stefania Tommasi4, A. Mangia4, Francesco Carpagnano5, Gaetano Stea2, Antonella Susca2, Giuseppe Di Gioia3, Mario De Lena4, and Angelo Paradiso4

1 Institute of Respiratory Disease, University of Foggia, Foggia, Italy, 2 ISPA, CNR, Bari, Italy, 3 Institute of Respiratory Disease, University of Bari, Bari, Italy, 4 Clinical Experimental Oncology Lab, National Cancer Institute, Bari, Italy, 5 Department of Thoracic Surgery, San Paolo Hospital, Bari, Italy

* To whom correspondence should be addressed. E-mail: ge.carpagnano{at}unifg.it.

Rationale: The still high mortality for lung cancer urgently requires the availability of new noninvasive diagnostic tools destined to more effective early diagnosis and screening programs. Recently, exhaled breath condensate (EBC) has been proposed as a useful tool to obtain biological information on lung cancer disease. Objectives: The present study checked for the feasibility of microsatellite alteration (MA) analysis in the EBC-DNA from NSCLC patients with respect to alterations found in whole blood (WB) DNA. Methods: Thirty patients with a histological evidence of NSCLC and 20 healthy subjects were enrolled. All subjects had allelotyping analysis on DNA from EBC and WB-DNA of a panel of microsatellites (D3S2338, D3S1266, D3S1300, D3S1304, D3S1289) located in chromosomal region 3p. Results from healthy and cancer subjects, and from EBC and WB were compared. Furthermore, the relationships with smoking habit and clinical- pathological tumour features were considered. Measurements and Main Results: MA were found in 53% of EBC-DNA and in 10% of WB-DNA loci investigated from NSCLC patients (p< 10-6); conversely, MA were present only in 13% in EBC-DNA and 2% in WB-DNAs informative loci of healthy subjects. In NSCLC patients a direct association between number of MA detected in EBC-DNA and tobacco consumption was observed. Conclusions: In the present paper, for the first time we provide evidence that EBC-DNA is highly sensitive in detecting MA from NSCLC and healthy subjects. Furthermore, MA information seem to be directly related with tobacco consumption and then, potentially applicable to screening and early diagnosis programs for NSCLC patients.


Key words: DNA,LOH,chromosome 3, NSCLC susceptibility




This article has been cited by other articles:


Home page
Eur Respir JHome page
I. Horvath, Z. Lazar, N. Gyulai, M. Kollai, and G. Losonczy
Exhaled biomarkers in lung cancer
Eur. Respir. J., July 1, 2009; 34(1): 261 - 275.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. Paradiso, S. Tommasi, R. Pinto, G. E. Carpagnano, and M. P. Foschino-Barbaro
Exhaled breath condensate is not suitable to detect EGFR somatic mutations
Eur. Respir. J., October 1, 2008; 32(4): 1126 - 1127.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. A. Powell
Waiting to Exhale
Am. J. Respir. Crit. Care Med., February 1, 2008; 177(3): 246 - 247.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. E. Carpagnano, M. P. Foschino-Barbaro, A. Spanevello, O. Resta, F. Carpagnano, G. Mule, R. Pinto, S. Tommasi, and A. Paradiso
3p Microsatellite Signature in Exhaled Breath Condensate and Tumor Tissue of Patients with Lung Cancer
Am. J. Respir. Crit. Care Med., February 1, 2008; 177(3): 337 - 341.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Respir DisHome page
P. Montuschi
Review: Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications
Therapeutic Advances in Respiratory Disease, October 1, 2007; 1(1): 5 - 23.
[Abstract] [PDF]


Home page
ChestHome page
P. B. Bach, G. A. Silvestri, M. Hanger, and J. R. Jett
Screening for Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 69S - 77S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Lucattelli, S. Fineschi, P. Geppetti, N. P. Gerard, and G. Lungarella
Neurokinin-1 Receptor Blockade and Murine Lung Tumorigenesis
Am. J. Respir. Crit. Care Med., September 15, 2006; 174(6): 674 - 683.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. R. Jett and Y. E. Miller
Update in lung cancer 2005.
Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 695 - 697.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society
  CCM abstracts